Press Release

Your NEXT Option™
May / 2023

Video: Expanded Phase 1 Program to the Dallas Area

Featured image for “Video: Expanded Phase 1 Program to the Dallas Area”
May / 2023

SA cancer research company entering Dallas market as it eyes more U.S., European expansion

Featured image for “SA cancer research company entering Dallas market as it eyes more U.S., European expansion”
Apr / 2023

NEXT Oncology Expands Phase I Program to Dallas Area

Featured image for “<strong>NEXT Oncology Expands Phase I Program to Dallas Area</strong>”
Jan / 2023

Grand Opening of joint venture brings access to proprietary Phase I program to more patients

Nov / 2022

Teon Therapeutics Announces First Patient Treated in Phase 1/2 Clinical Trial of TT-816, a Novel Oral Immune Checkpoint Inhibitor, in Patients with Advanced Solid Tumors

Featured image for “Teon Therapeutics Announces First Patient Treated in Phase 1/2 Clinical Trial of TT-816, a Novel Oral Immune Checkpoint Inhibitor, in Patients with Advanced Solid Tumors”
Oct / 2022

The Theresa Mays Endowed Merit Award Established for Promising Investigators Holding a PharmD Degree

Featured image for “The Theresa Mays Endowed Merit Award Established for Promising Investigators Holding a PharmD Degree”

Request Information From NEXT

We will respond to you with more information soon.
Contact NEXT